Krill Oil 500 mg
Natural health product licensed in Canada
- Other names
- Krill Oil, Omega-3, Pure Krill Oil, SUPER Omega-3 Krill Oil, SUPER Omega-3 Krill Oil 500 mg, Wild Krill Oil
- Licence holder
- WN Pharmaceuticals Ltd
- NPN or DIN-HM
- 80052036
- Status
- Active licence
- Licence date
- 24 June 2014
- Revision date
- 27 January 2015
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Huile de krill Source : Euphausia superba - en entier Potency : 30 mg Docosahexaenoic acid | 500 mg | Not calculated |
| Huile de krill Source : Euphausia superba - en entier Potency : 60 mg Eicosapentaenoic acid | Not specified | Not calculated |
| Huile de krill Source : Euphausia superba - en entier Potency : 120 mg Omega-3 Fatty acids | Not specified | Not calculated |
| Huile de krill Source : Euphausia superba - en entier Potency : 150 mcg Esterified astaxanthin | Not specified | Not calculated |
| Huile de krill Source : Euphausia superba - en entier Potency : 200 mg Phospholipids | Not specified | Not calculated |
Non-medicinal ingredients
Eau purifiée, Glycérine, Ethylvanilline, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 9 Capsule | 1 Tous les jours |
| Adultes | minimum: 19 years | 2 Capsule | 1 day |
Uses authorised in Canada
Source of omega-3 fatty acids for the maintenance of good health. Source of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) for the maintenance of good health. Helps to maintain/support cardiovascular health. Helps to relieve symptoms of dysmenorrheal and premenstrual syndrome. Helps to relieve symptoms of premenstrual syndrome. Helps to reduce serum triglycerides/triacylglycerols in conjunction with conventional statin therapy. Helps to reduce the levels of LDL cholesterol in conjunction with conventional statin therapy. Helps to increase the levels of HDL cholesterol in conjunction with statin therapy. Helps to reduce pain associated with osteoarthritis. Helps support brain function.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If you are pregnant or breastfeeding, consult a physician prior to use. Hypersensitivity/allergy has been known to occur with shellfish; if this occurs, discontinue use. Keep out of reach of children. Consult a health care practitioner prior to use if you are having coagulopathy problems (bleeding predispositions) or if you are taking anticoagulants.
Source
Official Health Canada record, licence 80052036
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2015. Photograph the packaging to check whether it has changed. Photograph the packaging